Robert Reis
Concepts (480)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Caenorhabditis elegans | 34 | 2024 | 138 | 4.230 |
Why?
| Longevity | 21 | 2019 | 80 | 2.210 |
Why?
| Alzheimer Disease | 9 | 2024 | 317 | 2.090 |
Why?
| Caenorhabditis elegans Proteins | 12 | 2019 | 56 | 1.620 |
Why?
| Aging | 21 | 2016 | 688 | 1.460 |
Why?
| Mutation | 19 | 2023 | 1293 | 1.020 |
Why?
| Phosphatidylinositol 3-Kinases | 6 | 2016 | 141 | 0.950 |
Why?
| Animals | 61 | 2024 | 13150 | 0.940 |
Why?
| Neurodegenerative Diseases | 4 | 2022 | 76 | 0.930 |
Why?
| Chromosome Mapping | 12 | 2006 | 160 | 0.780 |
Why?
| Recombination, Genetic | 14 | 2011 | 108 | 0.770 |
Why?
| Gene Regulatory Networks | 3 | 2019 | 107 | 0.760 |
Why?
| DNA, Mitochondrial | 7 | 2017 | 112 | 0.750 |
Why?
| Amyotrophic Lateral Sclerosis | 2 | 2023 | 39 | 0.740 |
Why?
| DNA | 18 | 2021 | 545 | 0.710 |
Why?
| Quantitative Trait Loci | 6 | 2006 | 42 | 0.700 |
Why?
| Phosphatidylinositol Phosphates | 3 | 2018 | 15 | 0.640 |
Why?
| Telomerase | 5 | 2017 | 27 | 0.630 |
Why?
| Amyloid beta-Peptides | 4 | 2021 | 69 | 0.590 |
Why?
| Peptide Fragments | 4 | 2021 | 216 | 0.540 |
Why?
| Proteins | 4 | 2018 | 341 | 0.510 |
Why?
| Rad51 Recombinase | 4 | 2015 | 21 | 0.510 |
Why?
| Genomic Instability | 2 | 2020 | 92 | 0.500 |
Why?
| 14-3-3 Proteins | 2 | 2022 | 18 | 0.500 |
Why?
| Oxidative Stress | 6 | 2012 | 768 | 0.470 |
Why?
| Aspirin | 2 | 2017 | 114 | 0.460 |
Why?
| DNA Replication | 7 | 2017 | 151 | 0.460 |
Why?
| Multiple Myeloma | 6 | 2020 | 2910 | 0.450 |
Why?
| Humans | 68 | 2023 | 49827 | 0.440 |
Why?
| Creutzfeldt-Jakob Syndrome | 1 | 2022 | 7 | 0.430 |
Why?
| Profilins | 2 | 2023 | 16 | 0.430 |
Why?
| Apolipoprotein E4 | 2 | 2024 | 19 | 0.420 |
Why?
| Lysosomes | 3 | 2024 | 64 | 0.420 |
Why?
| Peptide Nucleic Acids | 3 | 2015 | 17 | 0.400 |
Why?
| Benzylamines | 1 | 2021 | 15 | 0.390 |
Why?
| Huntington Disease | 1 | 2021 | 23 | 0.390 |
Why?
| Cholinesterase Inhibitors | 1 | 2021 | 26 | 0.390 |
Why?
| Peptide Chain Elongation, Translational | 1 | 2021 | 7 | 0.390 |
Why?
| Alkaloids | 1 | 2021 | 32 | 0.380 |
Why?
| Glutathione Transferase | 3 | 2006 | 174 | 0.380 |
Why?
| Autophagy | 2 | 2024 | 168 | 0.370 |
Why?
| Brain | 3 | 2018 | 1309 | 0.370 |
Why?
| Thiadiazoles | 1 | 2020 | 19 | 0.370 |
Why?
| Indoles | 2 | 2020 | 278 | 0.370 |
Why?
| Oxyquinoline | 1 | 2020 | 8 | 0.370 |
Why?
| Chelating Agents | 1 | 2020 | 27 | 0.370 |
Why?
| RNA | 2 | 2021 | 170 | 0.370 |
Why?
| Disease Models, Animal | 7 | 2021 | 1451 | 0.370 |
Why?
| Hematologic Neoplasms | 1 | 2022 | 99 | 0.360 |
Why?
| Stress, Physiological | 4 | 2015 | 170 | 0.360 |
Why?
| Neuroprotective Agents | 1 | 2021 | 105 | 0.360 |
Why?
| RNA Interference | 7 | 2016 | 179 | 0.350 |
Why?
| Drug Design | 1 | 2020 | 120 | 0.350 |
Why?
| Transcription, Genetic | 8 | 2015 | 371 | 0.340 |
Why?
| Mice | 16 | 2024 | 5720 | 0.340 |
Why?
| Transcriptome | 2 | 2019 | 313 | 0.340 |
Why?
| Fibroblasts | 21 | 2001 | 343 | 0.330 |
Why?
| DNA-Binding Proteins | 5 | 2021 | 436 | 0.330 |
Why?
| Protein Binding | 5 | 2018 | 660 | 0.330 |
Why?
| Somatomedins | 1 | 2018 | 32 | 0.320 |
Why?
| Simian virus 40 | 6 | 2002 | 14 | 0.320 |
Why?
| Hippocampus | 2 | 2021 | 228 | 0.320 |
Why?
| Hot Temperature | 4 | 2013 | 208 | 0.320 |
Why?
| Gene Expression Profiling | 5 | 2015 | 1031 | 0.320 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2018 | 114 | 0.310 |
Why?
| Lasers | 2 | 2021 | 119 | 0.310 |
Why?
| Codon, Nonsense | 3 | 2016 | 26 | 0.310 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 142 | 0.300 |
Why?
| Membrane Proteins | 2 | 2018 | 342 | 0.300 |
Why?
| Nucleotide Motifs | 1 | 2017 | 24 | 0.300 |
Why?
| Replication Origin | 1 | 2017 | 11 | 0.300 |
Why?
| Insulin | 2 | 2018 | 457 | 0.300 |
Why?
| RNA, Transfer | 1 | 2017 | 16 | 0.300 |
Why?
| Models, Genetic | 2 | 2015 | 174 | 0.280 |
Why?
| Computational Biology | 1 | 2018 | 214 | 0.280 |
Why?
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2016 | 10 | 0.280 |
Why?
| Muscles | 1 | 2016 | 103 | 0.280 |
Why?
| Caloric Restriction | 2 | 2015 | 34 | 0.270 |
Why?
| Antigens, Polyomavirus Transforming | 4 | 2002 | 9 | 0.270 |
Why?
| Molecular Docking Simulation | 3 | 2023 | 73 | 0.270 |
Why?
| Telomere | 4 | 2004 | 36 | 0.270 |
Why?
| Pyridinium Compounds | 1 | 2015 | 19 | 0.270 |
Why?
| Aldehydes | 2 | 2006 | 83 | 0.270 |
Why?
| Cyclin-Dependent Kinases | 1 | 2015 | 28 | 0.270 |
Why?
| Homologous Recombination | 1 | 2015 | 39 | 0.260 |
Why?
| Benzimidazoles | 1 | 2015 | 48 | 0.260 |
Why?
| Polymerase Chain Reaction | 8 | 2008 | 455 | 0.260 |
Why?
| Proprotein Convertases | 1 | 2015 | 8 | 0.260 |
Why?
| Serine Endopeptidases | 1 | 2015 | 52 | 0.250 |
Why?
| DNA Transposable Elements | 6 | 2005 | 107 | 0.250 |
Why?
| Repetitive Sequences, Nucleic Acid | 9 | 2000 | 97 | 0.250 |
Why?
| Myocytes, Smooth Muscle | 1 | 2015 | 87 | 0.250 |
Why?
| Protein Conformation | 3 | 2020 | 166 | 0.240 |
Why?
| Lipids | 2 | 2016 | 147 | 0.240 |
Why?
| Bone Density | 4 | 2006 | 379 | 0.240 |
Why?
| Microscopy, Fluorescence | 2 | 2012 | 162 | 0.240 |
Why?
| Melphalan | 1 | 2015 | 174 | 0.240 |
Why?
| Cryoprotective Agents | 1 | 2024 | 6 | 0.240 |
Why?
| Proteasome Inhibitors | 1 | 2014 | 104 | 0.230 |
Why?
| Cell Transformation, Neoplastic | 5 | 2001 | 177 | 0.230 |
Why?
| Cryopreservation | 1 | 2024 | 30 | 0.230 |
Why?
| Cell Line | 10 | 2018 | 1002 | 0.230 |
Why?
| Proteomics | 3 | 2018 | 328 | 0.230 |
Why?
| Models, Molecular | 3 | 2020 | 337 | 0.220 |
Why?
| Cell Division | 13 | 2004 | 292 | 0.220 |
Why?
| Mosquito Control | 1 | 2013 | 4 | 0.220 |
Why?
| Oligonucleotide Array Sequence Analysis | 4 | 2009 | 412 | 0.220 |
Why?
| Cell Survival | 10 | 2015 | 598 | 0.220 |
Why?
| Aedes | 1 | 2013 | 12 | 0.220 |
Why?
| Drug Resistance, Neoplasm | 1 | 2015 | 308 | 0.220 |
Why?
| Scavenger Receptors, Class E | 1 | 2015 | 204 | 0.220 |
Why?
| Gametogenesis | 1 | 2012 | 2 | 0.210 |
Why?
| Quantitative Trait, Heritable | 3 | 2001 | 16 | 0.210 |
Why?
| Computer Simulation | 3 | 2018 | 282 | 0.210 |
Why?
| Photoacoustic Techniques | 1 | 2013 | 68 | 0.210 |
Why?
| Cell Transformation, Viral | 4 | 2002 | 25 | 0.210 |
Why?
| Metal Nanoparticles | 1 | 2013 | 83 | 0.200 |
Why?
| Cell Line, Tumor | 6 | 2015 | 1402 | 0.200 |
Why?
| Microscopy, Confocal | 1 | 2012 | 87 | 0.200 |
Why?
| Binding Sites | 3 | 2020 | 377 | 0.200 |
Why?
| Gene Knockdown Techniques | 3 | 2016 | 106 | 0.200 |
Why?
| Signal Transduction | 4 | 2018 | 1617 | 0.200 |
Why?
| Gold | 1 | 2013 | 135 | 0.200 |
Why?
| Cells, Cultured | 16 | 2016 | 1571 | 0.200 |
Why?
| Fluorescent Dyes | 1 | 2012 | 101 | 0.200 |
Why?
| Down-Regulation | 2 | 2011 | 349 | 0.200 |
Why?
| Data Mining | 1 | 2011 | 40 | 0.200 |
Why?
| Hypoxanthine Phosphoribosyltransferase | 4 | 2001 | 21 | 0.190 |
Why?
| Alu Elements | 1 | 2011 | 7 | 0.190 |
Why?
| Cell Line, Transformed | 7 | 2017 | 72 | 0.190 |
Why?
| Gene Expression Regulation | 4 | 2009 | 979 | 0.190 |
Why?
| Barrett Esophagus | 1 | 2011 | 29 | 0.190 |
Why?
| Esophageal Neoplasms | 2 | 2011 | 99 | 0.190 |
Why?
| Genome, Human | 1 | 2011 | 111 | 0.180 |
Why?
| Dependovirus | 2 | 2002 | 101 | 0.180 |
Why?
| Plasmids | 8 | 2005 | 159 | 0.180 |
Why?
| Animals, Genetically Modified | 4 | 2018 | 49 | 0.180 |
Why?
| Werner Syndrome | 4 | 1991 | 15 | 0.180 |
Why?
| Obesity | 1 | 2018 | 1113 | 0.180 |
Why?
| Dose-Response Relationship, Drug | 4 | 2021 | 1374 | 0.180 |
Why?
| Histoplasma | 1 | 2009 | 27 | 0.170 |
Why?
| Genetic Markers | 5 | 2003 | 103 | 0.170 |
Why?
| Multigene Family | 3 | 1997 | 56 | 0.170 |
Why?
| Enzyme Inhibitors | 2 | 2003 | 391 | 0.170 |
Why?
| Histoplasmosis | 1 | 2009 | 50 | 0.170 |
Why?
| Bone and Bones | 1 | 2003 | 468 | 0.170 |
Why?
| Lipid Peroxidation | 2 | 2007 | 100 | 0.170 |
Why?
| Peptides | 2 | 2021 | 222 | 0.170 |
Why?
| Amino Acid Sequence | 2 | 2021 | 587 | 0.160 |
Why?
| Catalytic Domain | 2 | 2020 | 57 | 0.160 |
Why?
| Biopolymers | 1 | 2008 | 14 | 0.160 |
Why?
| Pattern Recognition, Automated | 1 | 2008 | 42 | 0.160 |
Why?
| Sequence Alignment | 1 | 2008 | 121 | 0.160 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 2008 | 67 | 0.160 |
Why?
| RNA, Messenger | 9 | 2017 | 1105 | 0.160 |
Why?
| Antineoplastic Agents | 2 | 2015 | 1172 | 0.160 |
Why?
| Spine | 2 | 2006 | 94 | 0.160 |
Why?
| Bone Diseases, Metabolic | 2 | 2000 | 74 | 0.150 |
Why?
| Adenocarcinoma | 2 | 2011 | 401 | 0.150 |
Why?
| DNA, Circular | 6 | 1990 | 18 | 0.150 |
Why?
| Genotype | 5 | 2017 | 538 | 0.150 |
Why?
| Artificial Intelligence | 1 | 2008 | 80 | 0.150 |
Why?
| X Chromosome | 1 | 2006 | 13 | 0.140 |
Why?
| Models, Animal | 3 | 2019 | 233 | 0.140 |
Why?
| Ubiquitin | 2 | 2018 | 45 | 0.140 |
Why?
| Apoptosis | 3 | 2004 | 1100 | 0.140 |
Why?
| Molecular Dynamics Simulation | 2 | 2017 | 33 | 0.130 |
Why?
| Receptor, Insulin | 1 | 2005 | 41 | 0.130 |
Why?
| Growth Inhibitors | 1 | 2005 | 27 | 0.130 |
Why?
| Chorionic Gonadotropin | 4 | 1990 | 18 | 0.130 |
Why?
| Selection, Genetic | 1 | 2005 | 24 | 0.130 |
Why?
| Genes, Helminth | 2 | 2006 | 5 | 0.130 |
Why?
| Phosphorylation | 2 | 2017 | 536 | 0.130 |
Why?
| Point Mutation | 1 | 2005 | 65 | 0.130 |
Why?
| Xenograft Model Antitumor Assays | 2 | 2015 | 210 | 0.120 |
Why?
| Recombinant Fusion Proteins | 2 | 2021 | 182 | 0.120 |
Why?
| Cell Death | 2 | 2016 | 181 | 0.120 |
Why?
| Up-Regulation | 2 | 2011 | 450 | 0.120 |
Why?
| Algorithms | 1 | 2008 | 616 | 0.120 |
Why?
| Genes, Viral | 2 | 2002 | 38 | 0.120 |
Why?
| Hydrogen Peroxide | 3 | 2016 | 114 | 0.120 |
Why?
| Genetic Predisposition to Disease | 2 | 2006 | 510 | 0.120 |
Why?
| Gene Expression Regulation, Neoplastic | 3 | 2015 | 829 | 0.120 |
Why?
| Oxazoles | 1 | 2004 | 8 | 0.120 |
Why?
| Porphyrins | 1 | 2003 | 11 | 0.110 |
Why?
| Reactive Oxygen Species | 3 | 2015 | 408 | 0.110 |
Why?
| Models, Biological | 7 | 2009 | 728 | 0.110 |
Why?
| Viral Proteins | 2 | 2002 | 155 | 0.110 |
Why?
| Guanosine Triphosphate | 1 | 2023 | 19 | 0.110 |
Why?
| Cloning, Molecular | 8 | 2000 | 189 | 0.110 |
Why?
| Transfection | 5 | 2008 | 357 | 0.110 |
Why?
| Tubulin | 1 | 2023 | 22 | 0.110 |
Why?
| Genes | 5 | 1996 | 34 | 0.110 |
Why?
| Microtubules | 1 | 2023 | 41 | 0.110 |
Why?
| Forkhead Transcription Factors | 3 | 2009 | 112 | 0.110 |
Why?
| Life Expectancy | 2 | 2012 | 34 | 0.110 |
Why?
| Time Factors | 5 | 2019 | 2912 | 0.110 |
Why?
| Saccharomyces cerevisiae | 2 | 2024 | 192 | 0.100 |
Why?
| Hematopoiesis | 1 | 2022 | 71 | 0.100 |
Why?
| Osteoporosis | 1 | 2003 | 146 | 0.100 |
Why?
| Gene Deletion | 2 | 2006 | 266 | 0.100 |
Why?
| Drosophila melanogaster | 2 | 2015 | 30 | 0.100 |
Why?
| Geriatrics | 1 | 2012 | 46 | 0.100 |
Why?
| Electrophorus | 1 | 2021 | 5 | 0.100 |
Why?
| Butyrylcholinesterase | 1 | 2021 | 8 | 0.100 |
Why?
| Epistasis, Genetic | 2 | 2017 | 30 | 0.100 |
Why?
| Acetylcholinesterase | 1 | 2021 | 19 | 0.100 |
Why?
| Coronary Artery Disease | 1 | 2005 | 274 | 0.100 |
Why?
| Horses | 1 | 2021 | 44 | 0.100 |
Why?
| Protein Folding | 1 | 2021 | 49 | 0.090 |
Why?
| Actins | 3 | 2018 | 118 | 0.090 |
Why?
| Disease Progression | 2 | 2017 | 822 | 0.090 |
Why?
| Taq Polymerase | 1 | 2000 | 4 | 0.090 |
Why?
| Ataxia Telangiectasia | 2 | 1999 | 6 | 0.090 |
Why?
| Base Pair Mismatch | 1 | 2000 | 22 | 0.090 |
Why?
| Hypertension | 1 | 2016 | 532 | 0.090 |
Why?
| Chemistry Techniques, Synthetic | 1 | 2020 | 20 | 0.090 |
Why?
| Food Deprivation | 1 | 2000 | 29 | 0.090 |
Why?
| Fungi | 2 | 1997 | 44 | 0.090 |
Why?
| Cardiovascular Diseases | 1 | 2016 | 440 | 0.090 |
Why?
| Molecular Structure | 1 | 2021 | 297 | 0.090 |
Why?
| RNA, Viral | 1 | 2021 | 125 | 0.090 |
Why?
| Protein Structure, Secondary | 1 | 2020 | 72 | 0.090 |
Why?
| Cell Cycle | 4 | 2004 | 232 | 0.090 |
Why?
| Drosophila | 2 | 1997 | 17 | 0.090 |
Why?
| Hematopoietic Stem Cells | 1 | 2022 | 184 | 0.090 |
Why?
| Glioma | 1 | 2021 | 79 | 0.090 |
Why?
| Structure-Activity Relationship | 1 | 2021 | 394 | 0.090 |
Why?
| RNA-Binding Proteins | 1 | 2021 | 124 | 0.090 |
Why?
| Loss of Heterozygosity | 2 | 2011 | 77 | 0.090 |
Why?
| HEK293 Cells | 1 | 2020 | 222 | 0.090 |
Why?
| Trans-Activators | 1 | 2001 | 134 | 0.090 |
Why?
| Transcription Factors | 3 | 2009 | 563 | 0.090 |
Why?
| Proteome | 1 | 2021 | 173 | 0.090 |
Why?
| Male | 13 | 2018 | 25093 | 0.090 |
Why?
| Anisomycin | 1 | 2019 | 3 | 0.090 |
Why?
| Dipyrone | 1 | 2019 | 3 | 0.090 |
Why?
| Camptothecin | 1 | 2019 | 16 | 0.080 |
Why?
| Species Specificity | 3 | 2006 | 193 | 0.080 |
Why?
| Survival Rate | 2 | 2013 | 905 | 0.080 |
Why?
| Benzazepines | 1 | 2019 | 19 | 0.080 |
Why?
| Azacitidine | 1 | 2019 | 34 | 0.080 |
Why?
| Gene Expression | 5 | 2006 | 608 | 0.080 |
Why?
| Protein Unfolding | 1 | 2018 | 6 | 0.080 |
Why?
| DNA Damage | 3 | 2015 | 301 | 0.080 |
Why?
| DNA Helicases | 1 | 2001 | 142 | 0.080 |
Why?
| Hydrogen Bonding | 1 | 2018 | 31 | 0.080 |
Why?
| Age Factors | 5 | 2016 | 1090 | 0.080 |
Why?
| Drug Evaluation | 1 | 2008 | 26 | 0.080 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 36 | 0.080 |
Why?
| Mutant Proteins | 1 | 2018 | 37 | 0.080 |
Why?
| Base Sequence | 7 | 1997 | 650 | 0.080 |
Why?
| DNA Nucleotidyltransferases | 1 | 1997 | 2 | 0.080 |
Why?
| Aging, Premature | 1 | 1997 | 5 | 0.080 |
Why?
| Mutagenicity Tests | 1 | 1997 | 41 | 0.080 |
Why?
| Integrases | 1 | 1997 | 43 | 0.080 |
Why?
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 13 | 0.080 |
Why?
| Apolipoprotein E3 | 1 | 2017 | 8 | 0.080 |
Why?
| Pharmaceutical Preparations | 1 | 2008 | 76 | 0.080 |
Why?
| Kaplan-Meier Estimate | 1 | 2019 | 469 | 0.080 |
Why?
| Mice, Knockout | 2 | 2015 | 841 | 0.080 |
Why?
| Halothane | 1 | 1997 | 3 | 0.080 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2017 | 73 | 0.070 |
Why?
| Nematoda | 1 | 1997 | 1 | 0.070 |
Why?
| Mammals | 3 | 2006 | 56 | 0.070 |
Why?
| Anesthetics, Inhalation | 1 | 1997 | 32 | 0.070 |
Why?
| Acetylation | 1 | 2017 | 99 | 0.070 |
Why?
| Mice, Transgenic | 1 | 2018 | 555 | 0.070 |
Why?
| Carrier Proteins | 1 | 2018 | 304 | 0.070 |
Why?
| Absorptiometry, Photon | 3 | 2006 | 154 | 0.070 |
Why?
| Intermediate Filament Proteins | 1 | 2016 | 12 | 0.070 |
Why?
| Detergents | 1 | 2016 | 16 | 0.070 |
Why?
| Thermodynamics | 1 | 2016 | 34 | 0.070 |
Why?
| tau Proteins | 1 | 2016 | 26 | 0.070 |
Why?
| Carcinogens | 1 | 1997 | 199 | 0.070 |
Why?
| Solubility | 1 | 2016 | 68 | 0.070 |
Why?
| Indolizines | 1 | 2015 | 5 | 0.070 |
Why?
| Skin | 3 | 1991 | 407 | 0.070 |
Why?
| Cyclic N-Oxides | 1 | 2015 | 12 | 0.070 |
Why?
| Ligands | 1 | 2016 | 204 | 0.070 |
Why?
| Synteny | 1 | 2005 | 7 | 0.070 |
Why?
| Mole Rats | 1 | 2015 | 1 | 0.070 |
Why?
| Polymorphism, Single Nucleotide | 3 | 2006 | 485 | 0.070 |
Why?
| Chromosomes, Human, X | 1 | 2005 | 19 | 0.070 |
Why?
| Principal Component Analysis | 1 | 2015 | 55 | 0.070 |
Why?
| Drug Synergism | 1 | 2015 | 150 | 0.060 |
Why?
| Mice, SCID | 1 | 2015 | 175 | 0.060 |
Why?
| S Phase | 1 | 2015 | 19 | 0.060 |
Why?
| Diploidy | 4 | 1997 | 26 | 0.060 |
Why?
| Genes, BRCA1 | 1 | 2015 | 19 | 0.060 |
Why?
| Neoplasms | 1 | 2005 | 1233 | 0.060 |
Why?
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 36 | 0.060 |
Why?
| Alleles | 2 | 2009 | 251 | 0.060 |
Why?
| Crosses, Genetic | 3 | 2005 | 31 | 0.060 |
Why?
| Mitochondria | 1 | 2008 | 397 | 0.060 |
Why?
| Promoter Regions, Genetic | 2 | 2008 | 477 | 0.060 |
Why?
| Fertility | 1 | 2014 | 28 | 0.060 |
Why?
| Fluorescent Antibody Technique | 1 | 2014 | 108 | 0.060 |
Why?
| Protein Multimerization | 1 | 2014 | 49 | 0.060 |
Why?
| Cytokines | 1 | 2017 | 612 | 0.060 |
Why?
| Hormesis | 1 | 2024 | 8 | 0.060 |
Why?
| Vitrification | 1 | 2024 | 4 | 0.060 |
Why?
| Phenotype | 2 | 2003 | 727 | 0.060 |
Why?
| Phylogeny | 1 | 1995 | 230 | 0.060 |
Why?
| Lipopolysaccharides | 1 | 2015 | 191 | 0.060 |
Why?
| Methylation | 7 | 1990 | 123 | 0.060 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2007 | 138 | 0.060 |
Why?
| Sequence Deletion | 1 | 1994 | 67 | 0.060 |
Why?
| Lipoproteins, LDL | 1 | 2015 | 170 | 0.060 |
Why?
| NF-kappa B | 1 | 2015 | 314 | 0.060 |
Why?
| Blotting, Western | 1 | 2014 | 602 | 0.060 |
Why?
| Mice, Congenic | 1 | 2003 | 7 | 0.060 |
Why?
| Endothelial Cells | 1 | 2015 | 269 | 0.060 |
Why?
| Genetic Techniques | 1 | 2003 | 14 | 0.060 |
Why?
| Case-Control Studies | 1 | 2016 | 1128 | 0.050 |
Why?
| DNA Restriction Enzymes | 6 | 1990 | 19 | 0.050 |
Why?
| Young Adult | 2 | 2016 | 3936 | 0.050 |
Why?
| Genes, Essential | 1 | 2012 | 12 | 0.050 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2013 | 184 | 0.050 |
Why?
| Biological Evolution | 1 | 2012 | 32 | 0.050 |
Why?
| Systems Biology | 1 | 2012 | 33 | 0.050 |
Why?
| Melanins | 1 | 2012 | 27 | 0.050 |
Why?
| Radiation Dosage | 1 | 2013 | 157 | 0.050 |
Why?
| Intracellular Space | 1 | 2012 | 25 | 0.050 |
Why?
| Databases, Genetic | 1 | 2012 | 88 | 0.050 |
Why?
| Locomotion | 1 | 2012 | 92 | 0.050 |
Why?
| Ribosomes | 1 | 1981 | 35 | 0.050 |
Why?
| Female | 9 | 2017 | 26329 | 0.050 |
Why?
| Gene Amplification | 3 | 1985 | 57 | 0.050 |
Why?
| Glycoside Hydrolases | 1 | 1991 | 17 | 0.050 |
Why?
| Clone Cells | 3 | 1997 | 74 | 0.050 |
Why?
| Gene Expression Regulation, Viral | 2 | 2002 | 48 | 0.050 |
Why?
| Oxidants | 1 | 2011 | 53 | 0.050 |
Why?
| Poly A | 1 | 1990 | 11 | 0.050 |
Why?
| Imaging, Three-Dimensional | 1 | 2012 | 149 | 0.050 |
Why?
| Glycoprotein Hormones, alpha Subunit | 1 | 1990 | 3 | 0.050 |
Why?
| Fatty Acids | 1 | 2011 | 143 | 0.050 |
Why?
| RNA-Directed DNA Polymerase | 1 | 1990 | 6 | 0.040 |
Why?
| Adult | 6 | 2016 | 13160 | 0.040 |
Why?
| Genes, ras | 1 | 1990 | 43 | 0.040 |
Why?
| Cytosine | 2 | 1990 | 30 | 0.040 |
Why?
| Reference Values | 2 | 2016 | 310 | 0.040 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 987 | 0.040 |
Why?
| Microscopy | 1 | 2009 | 56 | 0.040 |
Why?
| Protein Biosynthesis | 1 | 1981 | 253 | 0.040 |
Why?
| Aphidicolin | 2 | 2001 | 2 | 0.040 |
Why?
| Kidney | 1 | 2024 | 665 | 0.040 |
Why?
| Nucleic Acid Hybridization | 5 | 1985 | 54 | 0.040 |
Why?
| Aged, 80 and over | 1 | 2016 | 3125 | 0.040 |
Why?
| Proto-Oncogene Proteins | 1 | 1990 | 149 | 0.040 |
Why?
| Aged | 7 | 2016 | 9272 | 0.040 |
Why?
| Virulence | 1 | 2009 | 171 | 0.040 |
Why?
| Hydroxyurea | 2 | 2001 | 30 | 0.040 |
Why?
| DNA Primers | 2 | 2000 | 206 | 0.040 |
Why?
| Evolution, Molecular | 1 | 2009 | 99 | 0.040 |
Why?
| Diet | 1 | 2012 | 564 | 0.040 |
Why?
| Host-Pathogen Interactions | 1 | 2009 | 129 | 0.040 |
Why?
| RNA, Small Interfering | 1 | 2008 | 215 | 0.040 |
Why?
| Oogenesis | 1 | 2007 | 16 | 0.040 |
Why?
| Lesch-Nyhan Syndrome | 2 | 1997 | 2 | 0.040 |
Why?
| Electroporation | 2 | 2004 | 17 | 0.040 |
Why?
| Histones | 1 | 1989 | 315 | 0.040 |
Why?
| Middle Aged | 4 | 2016 | 11997 | 0.040 |
Why?
| Gene Library | 2 | 2000 | 44 | 0.040 |
Why?
| Genes, Insect | 1 | 2006 | 11 | 0.040 |
Why?
| Antigens, Viral, Tumor | 2 | 2001 | 6 | 0.030 |
Why?
| Mutagens | 1 | 2006 | 51 | 0.030 |
Why?
| Mutagenesis | 1 | 2006 | 60 | 0.030 |
Why?
| Environment | 1 | 2006 | 85 | 0.030 |
Why?
| Tissue Distribution | 1 | 2016 | 164 | 0.030 |
Why?
| Immunohistochemistry | 1 | 2008 | 971 | 0.030 |
Why?
| Liver | 1 | 1981 | 1109 | 0.030 |
Why?
| Myofibroblasts | 1 | 2016 | 49 | 0.030 |
Why?
| Regression Analysis | 1 | 2006 | 395 | 0.030 |
Why?
| Electrophoresis | 1 | 2005 | 16 | 0.030 |
Why?
| Isoenzymes | 1 | 2005 | 168 | 0.030 |
Why?
| Oncogenes | 1 | 1985 | 58 | 0.030 |
Why?
| Rats | 2 | 2005 | 3300 | 0.030 |
Why?
| Insulin-Like Growth Factor I | 1 | 2005 | 137 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2006 | 585 | 0.030 |
Why?
| Rats, Inbred F344 | 1 | 2005 | 196 | 0.030 |
Why?
| Stress, Psychological | 1 | 2006 | 260 | 0.030 |
Why?
| Ultraviolet Rays | 2 | 1997 | 51 | 0.030 |
Why?
| DNA Mutational Analysis | 1 | 2005 | 175 | 0.030 |
Why?
| Oligonucleotide Probes | 2 | 1996 | 17 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 181 | 0.030 |
Why?
| Sex Factors | 1 | 2006 | 693 | 0.030 |
Why?
| Cerebral Cortex | 1 | 2005 | 200 | 0.030 |
Why?
| Deoxyribonuclease I | 1 | 2003 | 34 | 0.030 |
Why?
| Animals, Congenic | 1 | 2003 | 3 | 0.030 |
Why?
| Animals, Inbred Strains | 1 | 2003 | 5 | 0.030 |
Why?
| Tumor Cells, Cultured | 1 | 2003 | 465 | 0.030 |
Why?
| DNA Repair | 1 | 2004 | 192 | 0.030 |
Why?
| G-Quadruplexes | 1 | 2003 | 80 | 0.030 |
Why?
| Internationality | 1 | 2012 | 36 | 0.030 |
Why?
| Molecular Sequence Data | 2 | 1995 | 797 | 0.030 |
Why?
| Nucleic Acid Denaturation | 2 | 1985 | 13 | 0.020 |
Why?
| Kinetics | 3 | 1991 | 626 | 0.020 |
Why?
| DNA, Viral | 1 | 2002 | 133 | 0.020 |
Why?
| Helper Viruses | 1 | 2001 | 6 | 0.020 |
Why?
| False Positive Reactions | 1 | 2001 | 63 | 0.020 |
Why?
| Homozygote | 1 | 2001 | 56 | 0.020 |
Why?
| Heterozygote | 1 | 2001 | 82 | 0.020 |
Why?
| Templates, Genetic | 1 | 2000 | 14 | 0.020 |
Why?
| Chromosomes, Artificial, Yeast | 1 | 2000 | 6 | 0.020 |
Why?
| Sequence Homology | 1 | 2000 | 20 | 0.020 |
Why?
| Larva | 1 | 2000 | 26 | 0.020 |
Why?
| Mice, Inbred AKR | 1 | 2000 | 6 | 0.020 |
Why?
| Blotting, Northern | 2 | 1991 | 109 | 0.020 |
Why?
| DNA, Complementary | 1 | 2000 | 135 | 0.020 |
Why?
| Polymorphism, Genetic | 1 | 2001 | 181 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 2001 | 157 | 0.020 |
Why?
| Amino Acid Metabolism, Inborn Errors | 1 | 1999 | 14 | 0.020 |
Why?
| Heat-Shock Proteins | 1 | 2000 | 99 | 0.020 |
Why?
| Enzyme Induction | 1 | 1999 | 80 | 0.020 |
Why?
| Mice, Inbred C57BL | 2 | 1997 | 1806 | 0.020 |
Why?
| Muscle, Skeletal | 1 | 2005 | 750 | 0.020 |
Why?
| Invertebrates | 1 | 1989 | 3 | 0.020 |
Why?
| Drug Therapy | 1 | 2008 | 46 | 0.020 |
Why?
| Molecular Probes | 1 | 1988 | 9 | 0.020 |
Why?
| Aminopterin | 1 | 1997 | 2 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2000 | 854 | 0.020 |
Why?
| Recombinases | 1 | 1997 | 9 | 0.020 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 66 | 0.020 |
Why?
| Hypoxanthine | 1 | 1997 | 4 | 0.020 |
Why?
| Viral Structural Proteins | 1 | 1997 | 5 | 0.020 |
Why?
| Thymidine | 1 | 1997 | 18 | 0.020 |
Why?
| Transformation, Genetic | 1 | 1997 | 17 | 0.020 |
Why?
| Sexual Behavior, Animal | 1 | 1997 | 6 | 0.020 |
Why?
| Culture Media | 1 | 1997 | 93 | 0.020 |
Why?
| Drug Resistance | 1 | 1997 | 63 | 0.020 |
Why?
| Methotrexate | 1 | 1997 | 67 | 0.020 |
Why?
| Centrifugation, Density Gradient | 1 | 1985 | 17 | 0.020 |
Why?
| DNA, Recombinant | 1 | 1985 | 15 | 0.020 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 1985 | 6 | 0.020 |
Why?
| Research Design | 1 | 1988 | 343 | 0.020 |
Why?
| DNA, Helminth | 1 | 1995 | 2 | 0.020 |
Why?
| Glucocorticoids | 1 | 1997 | 219 | 0.020 |
Why?
| Haplotypes | 1 | 2005 | 83 | 0.020 |
Why?
| Femur | 1 | 2005 | 133 | 0.020 |
Why?
| Dexamethasone | 1 | 1997 | 429 | 0.020 |
Why?
| Linear Models | 1 | 2005 | 281 | 0.020 |
Why?
| Child | 4 | 1985 | 6824 | 0.020 |
Why?
| Lumbar Vertebrae | 1 | 2005 | 98 | 0.020 |
Why?
| Base Composition | 2 | 1985 | 28 | 0.010 |
Why?
| Escherichia coli | 1 | 1985 | 186 | 0.010 |
Why?
| Blotting, Southern | 1 | 1994 | 43 | 0.010 |
Why?
| Extrachromosomal Inheritance | 1 | 1983 | 3 | 0.010 |
Why?
| Globins | 2 | 1982 | 14 | 0.010 |
Why?
| Polyribosomes | 1 | 1981 | 7 | 0.010 |
Why?
| Poly U | 1 | 1981 | 5 | 0.010 |
Why?
| Cell-Free System | 1 | 1981 | 13 | 0.010 |
Why?
| Mice, Inbred CBA | 1 | 1981 | 35 | 0.010 |
Why?
| alpha-Mannosidase | 1 | 1991 | 3 | 0.010 |
Why?
| beta-N-Acetylhexosaminidases | 1 | 1991 | 4 | 0.010 |
Why?
| Mannosidases | 1 | 1991 | 5 | 0.010 |
Why?
| beta-Galactosidase | 1 | 1991 | 33 | 0.010 |
Why?
| Glucuronidase | 1 | 1991 | 46 | 0.010 |
Why?
| Nucleotide Mapping | 1 | 1990 | 2 | 0.010 |
Why?
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 1990 | 5 | 0.010 |
Why?
| Nucleotides | 1 | 1990 | 23 | 0.010 |
Why?
| Genes, Regulator | 1 | 1990 | 4 | 0.010 |
Why?
| Electrophoresis, Agar Gel | 1 | 1990 | 12 | 0.010 |
Why?
| Restriction Mapping | 1 | 1990 | 33 | 0.010 |
Why?
| DNA Probes | 1 | 1990 | 30 | 0.010 |
Why?
| Contact Inhibition | 1 | 1989 | 3 | 0.010 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 1990 | 66 | 0.010 |
Why?
| Gene Rearrangement | 1 | 1989 | 74 | 0.010 |
Why?
| Genetic Variation | 1 | 1990 | 214 | 0.010 |
Why?
| Glycoproteins | 1 | 1989 | 115 | 0.010 |
Why?
| Treatment Outcome | 1 | 2008 | 5138 | 0.010 |
Why?
| Breeding | 1 | 1996 | 8 | 0.010 |
Why?
| Catalase | 1 | 1996 | 67 | 0.010 |
Why?
| 5-Methylcytosine | 1 | 1985 | 16 | 0.010 |
Why?
| Superoxide Dismutase | 1 | 1996 | 113 | 0.010 |
Why?
| Temperature | 1 | 1985 | 168 | 0.010 |
Why?
| Analysis of Variance | 1 | 1996 | 565 | 0.010 |
Why?
| Lymphocytes | 2 | 1985 | 151 | 0.010 |
Why?
| Proto-Oncogenes | 1 | 1985 | 27 | 0.000 |
Why?
| Chromosomes, Human | 1 | 1985 | 41 | 0.000 |
Why?
|
|
Reis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|